SERPINE1 and depressive symptom measurement: The sICAM-1, sVCAM-1, and PAI-1 levels in patients with first-episode schizophrenia spectrum disorder or depression did not significantly differ from those in patients with a chronic/recurrent state of either disease (data not shown in detail).